Amit M Oza

Amit M Oza, BSc, MD, MBBS, FRCPC

Dr. Amit Oza is a Senior Staff Physician and Professor of Medicine at the Princess Margaret Cancer Centre and the University of Toronto. He is cross-appointed to the Department of Obstetrics and Gynecology at the University of Toronto. He graduated from St. Bartholomew's Hospital, University of London (UK), in 1983 and completed his internal medicine and medical oncology training in UK. He completed Clinical Research Fellowships at St. Bartholomew's Hospital/Imperial Cancer Research Fund, London (UK), Princess Margaret Hospital, Toronto and at the Netherlands Cancer Institute, Amsterdam. His postgraduate research thesis was on Molecular Epidemiology of Hodgkin's Disease. He is a Fellow of the Royal College of Physicians of London and Canada.

Dr. Oza has been the principal investigator and co-investigator in phase I, II, and III trials for gynecological cancer and advanced colorectal malignancies. His research interests are focused towards the development, assessment and validation of novel therapeutic strategies for cancer including molecular targeted therapies. Many of these studies also incorporate novel endpoints and translational research which is developed in close relationship with scientists and pathologists from the OCI/PMH.

Dr. Oza has been the recipient of various awards such as the University of Toronto Award for Teaching Excellence for the Medical Oncology Training Program, the Hasselback Award for Teaching Excellence from Princess Margaret Hospital and many others. He has also been principal and co-author of numerous publications in major peer reviewed journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, Investigational New Drugs and Clinical Cancer Research.

He is currently interim Head, Department of Medical Oncology & Hematology, Co-Director of the Robert and Maggie Bras and Family Drug Development Program at the Princess Margaret Cancer Centre. This is the largest new drug development program in Canada and the only center outside the US to have a contract with the NIH for Early Phase Therapeutic studies. He is Co-Chair for the Gynecological Cancer Steering Committee of the National Cancer Institute and represents the Princess Margaret Phase II Consortium at the Gynecologic Cancer InterGroup.

Expert Opin Pharmacother. 2017 Mar 16;:
Kanjanapan Y, Lheureux S, Oza AM
Clin Cancer Res. 2017 Mar 06;:
Kristeleit R, Shapiro GI, Burris HA, Oza AM, LoRusso PM, Patel M, Domchek SM, Balmaña J, Drew Y, Chen LM, Safra T, Montes A, Giordano H, Maloney L, Goble S, Isaacson J, Xiao J, Borrow J, Rolfe L, Shapira-Frommer R
Clin Cancer Res. 2017 Feb 21;:
Lheureux S, Lai Z, Dougherty BA, Runswick S, Hodgson D, Timms KM, Lanchbury JS, Kaye SB, Gourley C, Bowtell DD, Kohn EC, Scott CL, Matulonis UA, Panzarella T, Karakasis K, Burnier JV, Gilks B, O'Connor MJ, Robertson JD, Ledermann J, Barrett JC, Ho TW,...
J Clin Oncol. 2017 Feb 21;:JCO2016713677
Lheureux S, Bruce JP, Burnier JV, Karakasis K, Shaw PA, Clarke BA, Yang SY, Quevedo R, Li T, Dowar M, Bowering V, Pugh TJ, Oza AM
Gynecol Oncol. 2017 Jan 03;:
Spreafico A, Oza AM, Clarke BA, Mackay HJ, Shaw P, Butler M, Dhani NC, Lheureux S, Wilson MK, Welch S, Zhang T, Yu C, Stockley T, Siu LL, Kamel-Reid S, Bedard PL
J Clin Oncol. 2011 May 20;29(15_suppl):5009
Oza AM, Poveda A, Clamp AR, Pignata S, Scambia G, Del Campo JM, McCormack M, Sevcik L, Schwartz BM, Guan S, Lee R, Cheng JD, Haluska FG
J Clin Oncol. 2011 May 20;29(15_suppl):5015
Morgan R, Oza AM, Qin R, Laumann KM, Mackay H, Strevel EL, Welch S, Sullivan D, Wenham RM, Chen HX, Doyle LA, Gandara DR, Erlichman C
J Clin Oncol. 2011 May 20;29(15_suppl):5013
Mackay H, Welch S, Tsao MS, Biagi JJ, Elit L, Ghatage P, Martin LA, Tonkin KS, Ellard S, Lau SK, McIntosh L, Eisenhauer EA, Oza AM
J Clin Oncol. 2011 May 20;29(15_suppl):5021
Matulonis U, Tew WP, Matei D, Behbakht K, Fleming GF, Oza AM
J Clin Oncol. 2011 May 20;29(15_suppl):5037
Townsley CA, Milosevic M, Haider MA, Mackay H, Yeung I, Kim S, Levin W, Manchul L, Bindra S, MacAlpine K, Tinker LM, Wang L, Quintos J, Fyles AW, Oza AM

Pages


 

Co-director, Robert and Maggie Bras and Family Drug Development Program​
Professor, Department of Medicine, University of Toronto
Head, Department of Medical Oncology & Hematology